SIGA
SIGA Technologies, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
3.15
close · 2026-09-14
value
77
cheaper than peers77
quality
71
stronger fundamentals71
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 2.92× | 95 |
| price to book | 1.37× | 79 |
| price to sales | 4.20× | 34 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.3% | 99 |
| operating margin | 33.9% | 84 |
| return on equity | -1.5% | 57 |
| revenue growth | -49.5% | 7 |
4 of 4 measures available
Facts
| market cap | $226M |
| free cash flow | -$24.0M |
| employees | 49 |
| first trade | 1997-09-10 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-31 |